Literature DB >> 3542094

Exercise and hypertension.

P M Zabetakis.   

Abstract

Entities:  

Mesh:

Year:  1986        PMID: 3542094      PMCID: PMC1629152     

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN: 0028-7091


× No keyword cloud information.
  21 in total

1.  Work activity and coronary heart mortality.

Authors:  R S Paffenbarger; W E Hale
Journal:  N Engl J Med       Date:  1975-03-13       Impact factor: 91.245

2.  Effects of physical training on coronary risk factors.

Authors:  J A Bonanno; J E Lies
Journal:  Am J Cardiol       Date:  1974-05-20       Impact factor: 2.778

3.  Exercise therapy in hypertensive men.

Authors:  J L Boyer; F W Kasch
Journal:  JAMA       Date:  1970-03-09       Impact factor: 56.272

4.  Haemodynamic effects of physical training in essential hypertension.

Authors:  J Ressl; J Chrástek; R Jandová
Journal:  Acta Cardiol       Date:  1977       Impact factor: 1.718

5.  Physical fitness prospects in the elderly.

Authors:  C Vallbona; S B Baker
Journal:  Arch Phys Med Rehabil       Date:  1984-04       Impact factor: 3.966

6.  The role of chronic exercise on resting blood pressures of normotensive and hypertensive rats.

Authors:  C M Tipton; R D Matthes; A Callahan; T K Tcheng; L Y Lais
Journal:  Med Sci Sports       Date:  1977

7.  Plasma osmolality, volume, and renin activity at the "anaerobic threshold".

Authors:  G W Gleim; P M Zabetakis; E E DePasquale; M F Michelis; J A Nicholas
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1984-01

8.  The effect of exercise training on human hypertension: a review.

Authors:  D R Seals; J M Hagberg
Journal:  Med Sci Sports Exerc       Date:  1984-06       Impact factor: 5.411

Review 9.  Profiling the hypertensive patient in sports.

Authors:  P M Zabetakis
Journal:  Clin Sports Med       Date:  1984-01       Impact factor: 2.182

10.  The Australian therapeutic trial in mild hypertension. Report by the Management Committee.

Authors: 
Journal:  Lancet       Date:  1980-06-14       Impact factor: 202.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.